DGIST researchers developed a deep learning model that classifies lung cancer exosomes based on physical properties measured by atomic force microscopy.
Key Details
- 1DGIST team used AFM to measure nanomechanical properties (stiffness, height-to-radius) of exosomes from NSCLC cell lines with different genetic mutations.
- 2AI model (DenseNet-121) classified exosomes by origin, achieving 96% accuracy and AUC of 0.92.
- 3Exosome stiffness reflected KRAS and EGFR mutations in their respective lung cancer cell lines.
- 4The method enables high-precision, label-free, liquid biopsy-based lung cancer diagnosis.
- 5Study published July 8, 2025, in Analytical Chemistry.
Why It Matters
This approach could offer a rapid, non-invasive way to diagnose lung cancer genetic mutations, reducing the need for tissue biopsies. Leveraging AI with nanomechanical imaging pushes boundaries in early cancer detection and personalized medicine.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.